News | September 08, 2011

MRI Study Suggests Brain Blood Vessel Abnormality May Be Factor in Parkinson's Disease

September 8, 2011 — A study in the journal Neurology International reveals a potentially treatable blood vessel abnormality in the brain may be the cause of Parkinson’s disease in some patients. A team of physicians and neuroscientists at Pittsburgh’s Allegheny General Hospital (AGH) conducted the study.

The study's lead author, Peter Jannetta, M.D., is credited with developing the modern surgical technique to treat such conditions. He is recognized worldwide as one of the preeminent authorities on diseases associated with vascular compression of cranial nerves.

Called microvascular decompression (MVD), the procedure involves repositioning compressive arteries in the brain and placing a protective pad between the artery and the structure it is compromising.

Jannetta first observed the possible role of vascular compression in Parkinson’s while treating a patient for the cranial nerve disease trigeminal neuralgia who also suffered from Parkinson’s. In addition to vascular compression of the left trigeminal nerve, the patient also had notable compression of an area of the brain called the left cerebral penduncle. The cerebral penduncles are two cylinder-like nerve bundles in the brainstem that act as a conduit for signals controlling motor functioning throughout the body.

After performing MVD of the left trigeminal nerve, Jannetta decompressed the patient's cerebral penduncle by mobilizing and repositioning the offending artery. The results were stunning. By post-operative day five, the patient's Parkinson's symptoms, including severe tremor and rigidity, had disappeared.

She remained symptom free for 18 months, after which she suffered a full recurrence. A follow-up magnetic resonance imaging (MRI) scan showed new compression of the non-treated right cerebral penduncle by the opposite posterior cerebral artery.

Based on this case, Jannetta and his AGH colleagues conducted a blinded MRI study analyzing the brains of 20 patients with Parkinson's and 20 healthy control subjects. The study showed 78 percent of the Parkinson's patients had visible arterial compression/distortion of one or both cerebral penduncles.

Of the study's 20 control subjects, just two had low-grade compression of the cerebral penduncle and one of those was subsequently diagnosed with Parkinson's.

A multi-center clinical trial to further explore the AGH team's premise has already been organized and is slated to begin later in 2011.

For more information: www.wpahs.org/locations/allegheny-general-hospital

Related Content

Bay Labs and Northwestern Medicine Enroll First Patient in AI Echocardiography Study
News | Cardiovascular Ultrasound | November 19, 2018
Medical artificial intelligence (AI) company Bay Labs and Northwestern Medicine announced that the first patient has...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...